There are several Phase 3 trials evaluating GLP-1s for conditions, such as prediabetes, Alzheimer's disease, diabetic retinopathy and osteoarthritis of the knee (in patients with obesity)
Semaglutide 2.5mg, presented in a compact 1ml vial, represents a groundbreaking addition to the functional medicine platform, specially designed to tackle the pressing issue of weight management and loss. This scientifically advanced formulation offers a potent solution for individuals striving to attain their weight loss goals in a holistic and sustainable manner. Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that has garnered substantial attention for its exceptional efficacy in promoting weight loss and improving metabolic health. Here's an in-depth exploration of the comprehensive benefits and applications of Semaglutide 2.5mg within the context of functional medicine for weight management

In a functional medicine practice, a clinician might consider a conversation about GHK Cu if someone: Is already addressing foundational longevity drivers (sleep, strength training, protein, glucose regulation) Has skin or connective tissue goals and wants evidence informed support Is in a repair phase after a period of high stress, illness, or inflammatory burden, and foundations are stable Wants a careful, monitored approach rather than internet protocols And we would still want to ask: What is your mineral status and overall nutrition status
Castaneda C, Marsden K, Maxwell T, Ten Eyck P, Kuwaye D, Kenne KA, et al